These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and Prognostic Value of Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860 [TBL] [Abstract][Full Text] [Related]
3. The value of lymph node ultrasound and whole body Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826 [TBL] [Abstract][Full Text] [Related]
4. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients. Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809 [TBL] [Abstract][Full Text] [Related]
5. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064 [TBL] [Abstract][Full Text] [Related]
6. Lawal I; Lengana T; Ololade K; Boshomane T; Reyneke F; Modiselle M; Vorster M; Sathekge M Nuklearmedizin; 2017 Jun; 56(3):83-89. PubMed ID: 28154879 [TBL] [Abstract][Full Text] [Related]
7. Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients. Helvind NM; Weitemeyer MB; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR Ann Surg Oncol; 2023 Apr; 30(4):2377-2388. PubMed ID: 36752970 [TBL] [Abstract][Full Text] [Related]
8. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence. Abbott RA; Acland KM; Harries M; O'Doherty M Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
10. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma. Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL Ann Surg Oncol; 2021 Aug; 28(8):4561-4569. PubMed ID: 33393039 [TBL] [Abstract][Full Text] [Related]
11. Surveillance strategies in the follow-up of melanoma patients: too much or not enough? Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057 [TBL] [Abstract][Full Text] [Related]
12. 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients. Toba H; Sakiyama S; Otsuka H; Kawakami Y; Takizawa H; Kenzaki K; Kondo K; Tangoku A Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):859-64. PubMed ID: 22914804 [TBL] [Abstract][Full Text] [Related]
13. The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma. Stahlie EHA; van der Hiel B; Stokkel MPM; Schrage YM; van Houdt WJ; Wouters MW; van Akkooi ACJ J Surg Oncol; 2020 Dec; 122(7):1328-1336. PubMed ID: 32783266 [TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management. Mena E; Taghipour M; Sheikhbahaei S; Mirpour S; Xiao J; Subramaniam RM Clin Nucl Med; 2016 Sep; 41(9):e403-9. PubMed ID: 27355846 [TBL] [Abstract][Full Text] [Related]
16. The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma. Twycross SH; Burger H; Holness J S Afr J Surg; 2019 Sep; 57(3):44-49. PubMed ID: 31392864 [TBL] [Abstract][Full Text] [Related]
17. Lack of clinical impact of Liu J; Larcos G; Howle J; Veness M Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma. Andersen JAS; Spatzek AD; Vilstrup MH; Grupe P; Hess S; Holdgaard PC; Bastholt L; Gerke O; Hildebrandt MG Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2342-2351. PubMed ID: 35129651 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538 [TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]